Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 KSG指南：非静脉曲张性上消化道出血

2020-09-15 国外消化科相关专家小组（统称） Gut Liver . 2020 Sep 15;14(5):560-570.

上消化道出血

2020年9月，韩国胃肠病学学会(KSG)发布了非静脉曲张性上消化道出血指南。非静脉曲张性上消化道出血（NVUGIB）是指Treitz韧带附近的胃肠道出血。NVUGIB需要住院治疗且与显著的发病率和死

中文标题：

2020 KSG指南：非静脉曲张性上消化道出血

英文标题：

Guidelines for Nonvariceal Upper Gastrointestinal Bleeding

发布机构：

国外消化科相关专家小组（统称）

发布日期：

2020-09-15

简要介绍：

2020年9月，韩国胃肠病学学会(KSG)发布了非静脉曲张性上消化道出血指南。非静脉曲张性上消化道出血（NVUGIB）是指Treitz韧带附近的胃肠道出血。NVUGIB需要住院治疗且与显著的发病率和死亡率相关。本文主要针对NVUGIB的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 KSG指南：非静脉曲张性上消化道出血.pdf)] GetToolGuiderByIdResponse(projectId=1, id=782671c0019800ea, title=2020 KSG指南：非静脉曲张性上消化道出血, enTitle=Guidelines for Nonvariceal Upper Gastrointestinal Bleeding, guiderFrom=Gut Liver . 2020 Sep 15;14(5):560-570., authorId=0, author=, summary=2020年9月，韩国胃肠病学学会(KSG)发布了非静脉曲张性上消化道出血指南。非静脉曲张性上消化道出血（NVUGIB）是指Treitz韧带附近的胃肠道出血。NVUGIB需要住院治疗且与显著的发病率和死, cover=https://img.medsci.cn/2020929/1601392862370_2020535.jpg, journalId=0, articlesId=null, associationId=950, associationName=国外消化科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Sep 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年9月，韩国胃肠病学学会(KSG)发布了非静脉曲张性上消化道出血指南。非静脉曲张性上消化道出血（NVUGIB）是指Treitz韧带附近的胃肠道出血。NVUGIB需要住院治疗且与显著的发病率和死亡率相关。本文主要针对NVUGIB的管理提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=660, tagName=上消化道出血)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=660, guiderKeyword=上消化道出血, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7327, appHits=418, showAppHits=0, pcHits=1632, showPcHits=6908, likes=4, shares=19, comments=27, approvalStatus=1, publishedTime=Wed Sep 30 00:26:26 CST 2020, publishedTimeString=2020-09-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 29 23:21:09 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:02:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 KSG指南：非静脉曲张性上消化道出血.pdf)])
2020 KSG指南：非静脉曲张性上消化道出血.pdf
下载请点击：
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081819, encodeId=bb701081819e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/80e06f57f49e47498c3231b1a1dc5a69/015d3e37fa3d441f9f14d5ff4974f867.jpg, createdBy=11fd5467302, createdName=ms1000000327018800, createdTime=Sun Dec 19 16:02:12 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064966, encodeId=2dde106496629, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a75457063, createdName=ms9000001679066842, createdTime=Fri Oct 29 13:29:45 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011617, encodeId=cf0b101161e52, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:01:06 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999733, encodeId=bd98999e3369, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLiaB0iaEcgjgpwAktr7UdLtlr3GctcIT0lod9ku49LdicibcibKUkBfwqJEoeWNLeTsiamoxeiccialvapXw/132, createdBy=21752501008, createdName=李洪520, createdTime=Thu Jul 15 13:47:53 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996056, encodeId=e4689960568c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dad5539561, createdName=ms2000001898877799, createdTime=Sun Jul 04 12:11:02 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-12-19 ms1000000327018800

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081819, encodeId=bb701081819e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/80e06f57f49e47498c3231b1a1dc5a69/015d3e37fa3d441f9f14d5ff4974f867.jpg, createdBy=11fd5467302, createdName=ms1000000327018800, createdTime=Sun Dec 19 16:02:12 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064966, encodeId=2dde106496629, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a75457063, createdName=ms9000001679066842, createdTime=Fri Oct 29 13:29:45 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011617, encodeId=cf0b101161e52, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:01:06 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999733, encodeId=bd98999e3369, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLiaB0iaEcgjgpwAktr7UdLtlr3GctcIT0lod9ku49LdicibcibKUkBfwqJEoeWNLeTsiamoxeiccialvapXw/132, createdBy=21752501008, createdName=李洪520, createdTime=Thu Jul 15 13:47:53 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996056, encodeId=e4689960568c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dad5539561, createdName=ms2000001898877799, createdTime=Sun Jul 04 12:11:02 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-10-29 ms9000001679066842

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081819, encodeId=bb701081819e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/80e06f57f49e47498c3231b1a1dc5a69/015d3e37fa3d441f9f14d5ff4974f867.jpg, createdBy=11fd5467302, createdName=ms1000000327018800, createdTime=Sun Dec 19 16:02:12 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064966, encodeId=2dde106496629, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a75457063, createdName=ms9000001679066842, createdTime=Fri Oct 29 13:29:45 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011617, encodeId=cf0b101161e52, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:01:06 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999733, encodeId=bd98999e3369, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLiaB0iaEcgjgpwAktr7UdLtlr3GctcIT0lod9ku49LdicibcibKUkBfwqJEoeWNLeTsiamoxeiccialvapXw/132, createdBy=21752501008, createdName=李洪520, createdTime=Thu Jul 15 13:47:53 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996056, encodeId=e4689960568c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dad5539561, createdName=ms2000001898877799, createdTime=Sun Jul 04 12:11:02 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-08-26 未来将来

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1081819, encodeId=bb701081819e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/80e06f57f49e47498c3231b1a1dc5a69/015d3e37fa3d441f9f14d5ff4974f867.jpg, createdBy=11fd5467302, createdName=ms1000000327018800, createdTime=Sun Dec 19 16:02:12 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064966, encodeId=2dde106496629, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a75457063, createdName=ms9000001679066842, createdTime=Fri Oct 29 13:29:45 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011617, encodeId=cf0b101161e52, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:01:06 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999733, encodeId=bd98999e3369, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLiaB0iaEcgjgpwAktr7UdLtlr3GctcIT0lod9ku49LdicibcibKUkBfwqJEoeWNLeTsiamoxeiccialvapXw/132, createdBy=21752501008, createdName=李洪520, createdTime=Thu Jul 15 13:47:53 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996056, encodeId=e4689960568c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dad5539561, createdName=ms2000001898877799, createdTime=Sun Jul 04 12:11:02 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-15 李洪520

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1081819, encodeId=bb701081819e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/80e06f57f49e47498c3231b1a1dc5a69/015d3e37fa3d441f9f14d5ff4974f867.jpg, createdBy=11fd5467302, createdName=ms1000000327018800, createdTime=Sun Dec 19 16:02:12 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064966, encodeId=2dde106496629, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a75457063, createdName=ms9000001679066842, createdTime=Fri Oct 29 13:29:45 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011617, encodeId=cf0b101161e52, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:01:06 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999733, encodeId=bd98999e3369, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLiaB0iaEcgjgpwAktr7UdLtlr3GctcIT0lod9ku49LdicibcibKUkBfwqJEoeWNLeTsiamoxeiccialvapXw/132, createdBy=21752501008, createdName=李洪520, createdTime=Thu Jul 15 13:47:53 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996056, encodeId=e4689960568c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dad5539561, createdName=ms2000001898877799, createdTime=Sun Jul 04 12:11:02 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 ms2000001898877799

    不错

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

急性非静脉曲张性上消化道出血诊治指南(2015 年,南昌)

中华医学会消化内镜学分会 · 2016-04-27

拓展阅读

急性非静脉曲张性上消化道出血诊治指南(2015 年,南昌)

中华医学会消化内镜学分会 · 2016-04-27

急性上消化道出血急诊诊治流程专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2021-01-10

非静脉曲张性上消化道出血（NVUGIH）的内窥镜诊断和处理：欧洲胃肠内窥镜学会（ESGE）指南-2021年更新。

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2021-02-12

2021 ESGE指南：非静脉曲张性上消化道出血的内镜诊断和治疗（更新版）

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2021-02-10

急性非静脉曲张性上消化道出血治疗药物临床试验技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2021-05-14

急性非静脉曲张性上消化道出血治疗药物临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2021-10-06

Baidu
map
Baidu
map
Baidu
map